In vitro Fertilization Devices and Consumables Market by Device (Sperm Separation System, Cryosystem, Incubators, Imaging System, Ovum Aspiration Pump, Cabinet, Micromanipulator system, Accessories and Disposables), Reagents & Media (Cryopreservation Media, Semen Processing Media, Ovum Processing Media, Embryo Culture Media), Technique (Fresh Embryo IVF, Frozen Egg IVF, Donor Egg IVF) and End User (Clinics, Hospitals, Surgical Centres, Clinical Research Institutes) - Opportunities and Forecasts, 2014 - 2020
In vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is a widely popular treatment, adopted by couples with infertility problems, single mothers, and the LGBT community to procreate.
The world in vitro fertilization devices and consumables market is projected to garner $3,025.2 mllion by 2020, registering a CAGR of 19.7% over the forecast period. The world IVF devices & consumables market is growing significantly owing to rising incidences of infertility, developments in IVF procedures, and growing healthcare expenditures. Furthermore, the rising awareness about infertility and easy availability of IVF treatments, would drive the market growth. Recent technological innovations in the IVF technology, such as embryoscope and capsule IVF, are expected to drive the demand for IVF devices and consumables in future. However, strenuous maintenance issues and inherent high cost associated with the devices limit the growth of the market. The shift in adoption of conventional infertility treatments such as infertility-medication (clomid), to the advanced IVF technologies would boost numerous growth opportunities for the IVF devices market. However, unaffordability of high-end IVF devices is the major challenge faced by local IVF clinics.
The world IVF devices market is segmented into IVF devices, reagent & media, techniques, end users, and geography. The devices considered in this report include sperm separation system, cryosystem, incubator, imaging system, ovum aspiration pump, IVF cabinet, micromanipulator, and IVF-accessories & disposables among others. The capital equipment set up is the fastest growing segment owing to the increasing number of newly established IVF centers. However, disposables and consumables used during IVF procedures are the highest revenue generating segments.
Based on reagents & media, the market is categorized into, cryopreservation media, semen processing media, ovum processing media and embryo culture media. Cryopreservation media is the highest revenue generating segment owing to its large application during frozen IVF cycles. IVF devices and consumables market by techniques is categorized into, fresh embryo IVF, frozen egg IVF and donor egg IVF. Fresh embryo IVF cycles is the largest revenue generating segment, owing to growing number of couples opting for fresh IVF cycles. The world IVF devices market by end-users is segmented into clinics, hospitals, surgical centres and clinical research institutes. Fertility clinic is the highest revenue generating segment, owing to short patient wait time and higher success rate.
The world IVF devices market is analysed on the basis of geographical regions into North America, Europe, Asia-Pacific, and LAMEA. North America and Europe are the leading revenue generating regions, collectively accounted for about 80% of the market share in 2015. However, the Asia-Pacific region would be the fastest growing region, owing to the high demand for economic IVF services and availability of skilled workforce.Product launch is one of the key strategies adopted by prominent players in the IVF devices and consumables market for the launch of micromanipulators systems, ovum aspiration pumps and IVF accessories among others. These technologies are used in both clinical and research fields. Companies profiled in this report include Vitrolife AB, EMD Serono, Inc., Irvine Scientific, CooperSurgical, Inc., Cook Medical, Inc., Thermo Fisher Scientific, Inc., Genea Biomedx, Auxogyn, Inc., Oxford Gene Technology, and OvaScience Inc.
KEY MARKET BENEFITS
The world IVF devices market is segmented on the basis of instruments, reagents & media, techniques, end users, and geography.
The world in vitro fertilization devices and consumables market is projected to garner $3,025.2 mllion by 2020, registering a CAGR of 19.7% over the forecast period. The world IVF devices & consumables market is growing significantly owing to rising incidences of infertility, developments in IVF procedures, and growing healthcare expenditures. Furthermore, the rising awareness about infertility and easy availability of IVF treatments, would drive the market growth. Recent technological innovations in the IVF technology, such as embryoscope and capsule IVF, are expected to drive the demand for IVF devices and consumables in future. However, strenuous maintenance issues and inherent high cost associated with the devices limit the growth of the market. The shift in adoption of conventional infertility treatments such as infertility-medication (clomid), to the advanced IVF technologies would boost numerous growth opportunities for the IVF devices market. However, unaffordability of high-end IVF devices is the major challenge faced by local IVF clinics.
The world IVF devices market is segmented into IVF devices, reagent & media, techniques, end users, and geography. The devices considered in this report include sperm separation system, cryosystem, incubator, imaging system, ovum aspiration pump, IVF cabinet, micromanipulator, and IVF-accessories & disposables among others. The capital equipment set up is the fastest growing segment owing to the increasing number of newly established IVF centers. However, disposables and consumables used during IVF procedures are the highest revenue generating segments.
Based on reagents & media, the market is categorized into, cryopreservation media, semen processing media, ovum processing media and embryo culture media. Cryopreservation media is the highest revenue generating segment owing to its large application during frozen IVF cycles. IVF devices and consumables market by techniques is categorized into, fresh embryo IVF, frozen egg IVF and donor egg IVF. Fresh embryo IVF cycles is the largest revenue generating segment, owing to growing number of couples opting for fresh IVF cycles. The world IVF devices market by end-users is segmented into clinics, hospitals, surgical centres and clinical research institutes. Fertility clinic is the highest revenue generating segment, owing to short patient wait time and higher success rate.
The world IVF devices market is analysed on the basis of geographical regions into North America, Europe, Asia-Pacific, and LAMEA. North America and Europe are the leading revenue generating regions, collectively accounted for about 80% of the market share in 2015. However, the Asia-Pacific region would be the fastest growing region, owing to the high demand for economic IVF services and availability of skilled workforce.Product launch is one of the key strategies adopted by prominent players in the IVF devices and consumables market for the launch of micromanipulators systems, ovum aspiration pumps and IVF accessories among others. These technologies are used in both clinical and research fields. Companies profiled in this report include Vitrolife AB, EMD Serono, Inc., Irvine Scientific, CooperSurgical, Inc., Cook Medical, Inc., Thermo Fisher Scientific, Inc., Genea Biomedx, Auxogyn, Inc., Oxford Gene Technology, and OvaScience Inc.
KEY MARKET BENEFITS
- An in-depth analysis of current research and clinical developments within world IVF devices market is provided with key market dynamic factors that help in understanding the behavior of market.
- The report provides quantitative analysis of the current market and estimations through 2014-2020, which assists in identifying the prevailing market opportunities.
- A comprehensive analysis of the market scenario in terms of devices, accessories & disposables and reagents & media helps in identifying the prevailing opportunities in the world IVF devices & consumables market.
- An in-depth analysis of current research and developments in the world IVF devices and consumables market provides key market dynamic factors shapes the market dynamics.
- Geographically, the world IVF devices and consumables market is analyzed based on various regions such as North America, Europe, Asia-Pacific, and LAMEA.
- Competitive intelligence (of leading manufacturers and distributors of IVF devices) highlights the business practices followed by leading market players across the geographies.
- SWOT analysis enables to study the internal environment of prominent companies for strategy formulation.
- Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders.
The world IVF devices market is segmented on the basis of instruments, reagents & media, techniques, end users, and geography.
- By Device
- Sperm Separation System
- Cryosystem
- Incubators
- Imaging System
- Ovum Aspiration Pump
- Cabinet
- Micromanipulator system
- Accessories and Disposables
- Others
- By Reagents & Media
- Cryopreservation Media
- Semen Processing Media
- Ovum Processing Media
- Embryo Culture Media
- By Technique
- Fresh Embryo IVF
- Frozen Egg IVF
- Donor Egg IVF
- By End User
- Clinics
- Hospitals
- Surgical Centres
- Clinical Research Institutes
- By Geography
- North America
- United States
- Canada
- Mexico
- Europe
- France
- Germany
- United Kingdom
- Other Europe
- Asia-Pacific
- China
- India
- Japan
- Australia
- Others
- LAMEA
- Latin America
- The Middle East
- Africa
CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key market benefits
1.3 Key market segments
1.4 Key audiences
1.5 Research methodology
1.1.1 Secondary research
1.1.2 Primary research
1.1.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 GLOBAL IVF DEVICES & CONSUMABLES MARKET OVERVIEW
3.1 Market definition and scope
3.2 Alternative technologies
3.2.1 Intrauterine Insemination (IUI) Technique
3.2.1.1 Factors assessed for the procedure
3.2.1.2 Benefits of this technique
3.2.1.3 Risks
3.2.2 Difference between IUI and IVF technique
3.2.3 GIFT technique
3.2.3.1 Difference between GIFT and IVF technique
3.2.4 ZIFT technique
3.2.4.1 Differences between ZIFT and IVF technique
3.3 Replacing IVF procedures by fertility drugs and surgeries
3.3.1 Female infertility treatments
3.3.1.1 Limitations of fertility drugs
3.3.2 Male infertility treatments
3.4 Costs related to IVF procedures
3.5 Role of donors in the IVF market
3.5.1 Egg donation
3.5.2 Egg sharing
3.5.3 Sperm donation
3.5.4 Embryo donation/adoption
3.5.5 Donation for research
3.6 Surrogacy
3.6.1 Legal issues
3.7 IVF trends in same sex couples
3.7.1 Artificial insemination
3.7.2 Surrogate mothers
3.7.3 In-vitro fertilization
3.8 Advanced IVF technologies
3.8.1 Capsule IVF
3.8.2 Three parent IVF
3.8.2.1 Ethical concerns
3.8.3 Mini IVF
3.8.3.1 Advantages
3.8.3.2 Drawbacks
3.8.4 EmbryoScope
3.8.4.1 Advantages
3.8.5 PICSI
3.9 Fertility treatment and gender selection
3.9.1 Methods of sex selection
3.9.1.1 Gradient method
3.9.1.2 Flow cytometry technique
3.9.1.3 Pre-implantation genetic diagnosis (PGD)
3.9.1.4 Ethical and legal issues
3.10 Metabolomics in embryo screening methods
3.11 Application of stem cells in IVF
3.12 IVF and resource poor countries
3.13 Key Findings
3.13.1 Top factors impacting
3.13.2 Top investment pockets
3.13.3 Top winning strategies
3.14 Porters five forces analysis
3.14.1 High competition and large number reduces the power of suppliers
3.14.2 Scattered nature and large count of end users moderates the buyer power
3.14.3 High capital cost lowers the threat of new entrants
3.14.4 Industry rivalry is intense due to presence of few dominant competitors
3.14.5 Lack of efficient substitutes lowers the threat from substitutes
3.15 Value chain analysis
3.16 Patent analysis
3.16.1 Patent analysis by type of patents
3.16.2 Patents Analysis by geography
3.17 Regulatory issues and legislations
3.18 Insurance reimbursement scenario
3.19 Clinical trials
3.19.1 Trial 1: To study the DHEA outcomes on poor responders of IVF
3.19.2 Trial 2: Use of Metformin in IVF treatment of polycystic ovary syndrome
3.19.3 Trial 3- Treatment of first line unexplained infertility by IVF and IUI in controlled ovarian stimulation
3.19.4 Trial 4: Fast track to IVF (FASTT) Vs conventional infertility treatment
3.19.5 Trial 5: To study the evaluation of multiple doses of NT100 in women with repeated IVF failures
3.20 Drivers
3.20.1 Delayed pregnancies in women
3.20.2 Rise in global infertility rates
3.20.3 Advancement in technology
3.20.4 Rise in gamete donations
3.20.5 Rise in disposable income
3.20.6 Increase in success rates
3.21 Restraints
3.21.1 Cost constraints
3.21.2 Ethical and legal issues
3.21.3 Multiple pregnancies
3.21.4 Low awareness level
3.22 Opportunities
3.22.1 Fertility tourism
3.22.2 Growing number of fertility clinics
3.22.3 Rise in same sex marriages
CHAPTER 4 GLOBAL IVF DEVICES & CONSUMABLES MARKET BY INSTRUMENTS
4.1 Global IVF market by instrument, 2014-2020, ($million)
4.1.1 Incubators
4.1.1.1 Global IVF incubators market by geography
4.1.2 Cryosystem
4.1.2.1 Global IVF cryosystem market by geography
4.1.3 Imaging system
4.1.3.1 Global IVF Imaging system market by geography
4.1.4 Cabinet (work station)
4.1.4.1 Global IVF cabinets market by geography
4.1.5 Ovum aspiration pump
4.1.5.1 Global IVF ovum aspiration pump market by geography
4.1.6 Sperm separation system
4.1.6.1 Global IVF Sperm separation system market by geography
4.1.7 Micro manipulator system
4.1.7.1 Global IVF Micromanipulator market by geography
4.1.8 Others
4.1.8.1 Global IVF other instruments market by geography
4.2 Accessories and disposables
4.2.1 Semen analysis chamber
4.2.2 Plastic ware
4.2.3 Oocyte retrieval needles
4.2.4 Miscellaneous disposables
4.2.5 Global IVF accessories and disposables market by geography
CHAPTER 5 GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY REAGENTS & MEDIA
5.1 Global IVF market by reagents & media, 2014-2020, ($million)
5.2 Cryopreservation media
5.2.1 Embryo cryopreservation media
5.2.2 Sperm cryopreservation media
5.2.3 Oocyte cryopreservation media
5.2.4 Global IVF cryopreservation media market by geography
5.3 Semen processing media
5.3.1 Global IVF semen processing media market by geography
5.4 Ovum processing media
5.4.1 Global IVF ovum processing media market by geography
5.5 Embryo culture media
5.5.1 Global IVF embryo culture media market by geography
CHAPTER 6 GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY TECHNIQUE
6.1 Global IVF market, by technique, 2014-2020 ($Million)
6.2 Fresh embryo transfer technique
6.2.1 Drivers
6.2.1.1 trends of Delayed pregnancies
6.2.1.2 Growing rates of infertility
6.2.2 Restraints
6.2.2.1 Cost involved in the treatment
6.2.2.2 reimbursements issues with fresh embryo ivf cycles
6.2.3 Global fresh embryo IVF cycle market, by geography
6.3 Frozen Embryo Transfer technique (FER)
6.3.1 Reasons to use this technique
6.3.2 Advantages of Frozen egg IVF technique
6.3.3 Disadvantages of frozen egg IVF technique
6.3.4 Global frozen egg IVF cycle market, by geography
6.4 Donor Egg IVF technique
6.4.1 Benefits of donor egg IVF technique
6.4.2 Risks associated with donor egg IVF cycle technique
6.4.3 Global donor egg IVF cycle market by geography
CHAPTER 7 GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY END USERS
7.1 Global IVF market by end user, 2014-2020 ($Million)
7.2 Hospitals
7.2.1 Global IVF hospitals market by geography
7.3 Surgical centers
7.4 Clinical research institutes
7.4.1 Global IVF clinical research institutes market by geography
7.5 Clinics
7.5.1 Global IVF Clinics market by geography
CHAPTER 8 GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY GEOGRAPHY
8.1 North America
8.1.1 North America IVF devices and consumables market, by country
8.1.1.1 United States IVF devices and consumables market
8.1.1.2 Canada IVF devices and consumables market
8.1.1.3 Mexico IVF devices and consumables market
8.2 Europe
8.2.1 Europe IVF devices and consumables market, by component
8.2.1.1 Germany IVF devices and consumables market
8.2.1.2 France IVF devices and consumables market
8.2.1.3 United Kingdom IVF devices and consumables market
8.2.1.4 Other Europe IVF devices and consumables market
8.3 Asia-Pacific
8.3.1 Asia-Pacific IVF devices & consumables market, by component
8.3.1.1 India IVF devices & consumables market
8.3.1.2 China IVF devices & consumables market
8.3.1.3 Japan IVF devices & consumables market
8.3.1.4 Australia IVF devices & consumables market
8.3.1.5 other Asia-pacific IVF devices & consumables market
8.4 LAMEA
8.4.1 LAMEA IVF devices & consumables market, by component
8.4.1.1 Latin America IVF devices & consumables market
8.4.1.2 Middle East IVF devices & consumables market
8.4.1.3 Africa IVF devices & consumables market
CHAPTER 9 COMPANY PROFILE
9.1 Vitrolife AB
9.1.1 Company overview
9.1.2 Business performance
9.1.3 Strategic moves and developments
9.1.4 SWOT analysis of Vitrolife AB
9.2 EMD Serono, Inc.
9.2.1 Company overview
9.2.2 Business performance
9.2.3 Strategic moves and developments
9.2.4 SWOT analysis of EMD Serono, Inc.
9.3 Irvine Scientific
9.3.1 Company overview
9.3.2 Business performance
9.3.3 Strategic moves and developments
9.3.4 SWOT analysis of Irvine scientific
9.4 CooperSurgical, Inc. (Origio)
9.4.1 Company overview
9.4.2 Business performance
9.4.3 Strategic moves and developments
9.4.4 SWOT analysis of CooperSurgical, Inc.
9.5 Cook Medical, Inc.
9.5.1 Company overview
9.5.2 Strategic moves and developments
9.5.3 SWOT analysis of Cook medical, Inc.
9.6 Thermo Fisher Scientific Inc.
9.6.1 Company overview:
9.6.2 Business performance
9.6.3 Strategic moves and developments
9.6.4 SWOT analysis of Thermo Fisher Scientific, Inc.
9.7 Genea Biomedx
9.7.1 Company overview
9.7.2 Strategic moves and developments
9.7.3 SWOT Analysis of Genea Biomedx
9.8 Auxogyn, Inc.
9.8.1 Company overview
9.8.2 Strategic moves and developments
9.8.2.1 Primary strategies
9.8.2.2 Other strategies
9.8.3 SWOT Analysis of Auxogyn, Inc.
9.9 Oxford Gene Technology
9.9.1 Company overview
9.9.2 Strategic moves and developments
9.9.3 SWOT analysis of Oxford Gene Technology
9.10 Ovascience Inc.
9.10.1 Company overview
9.10.2 Business performance
9.10.3 Strategic moves and developments
9.10.4 SWOT analysis of OvaScience, Inc.
1.1 Report description
1.2 Key market benefits
1.3 Key market segments
1.4 Key audiences
1.5 Research methodology
1.1.1 Secondary research
1.1.2 Primary research
1.1.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 GLOBAL IVF DEVICES & CONSUMABLES MARKET OVERVIEW
3.1 Market definition and scope
3.2 Alternative technologies
3.2.1 Intrauterine Insemination (IUI) Technique
3.2.1.1 Factors assessed for the procedure
3.2.1.2 Benefits of this technique
3.2.1.3 Risks
3.2.2 Difference between IUI and IVF technique
3.2.3 GIFT technique
3.2.3.1 Difference between GIFT and IVF technique
3.2.4 ZIFT technique
3.2.4.1 Differences between ZIFT and IVF technique
3.3 Replacing IVF procedures by fertility drugs and surgeries
3.3.1 Female infertility treatments
3.3.1.1 Limitations of fertility drugs
3.3.2 Male infertility treatments
3.4 Costs related to IVF procedures
3.5 Role of donors in the IVF market
3.5.1 Egg donation
3.5.2 Egg sharing
3.5.3 Sperm donation
3.5.4 Embryo donation/adoption
3.5.5 Donation for research
3.6 Surrogacy
3.6.1 Legal issues
3.7 IVF trends in same sex couples
3.7.1 Artificial insemination
3.7.2 Surrogate mothers
3.7.3 In-vitro fertilization
3.8 Advanced IVF technologies
3.8.1 Capsule IVF
3.8.2 Three parent IVF
3.8.2.1 Ethical concerns
3.8.3 Mini IVF
3.8.3.1 Advantages
3.8.3.2 Drawbacks
3.8.4 EmbryoScope
3.8.4.1 Advantages
3.8.5 PICSI
3.9 Fertility treatment and gender selection
3.9.1 Methods of sex selection
3.9.1.1 Gradient method
3.9.1.2 Flow cytometry technique
3.9.1.3 Pre-implantation genetic diagnosis (PGD)
3.9.1.4 Ethical and legal issues
3.10 Metabolomics in embryo screening methods
3.11 Application of stem cells in IVF
3.12 IVF and resource poor countries
3.13 Key Findings
3.13.1 Top factors impacting
3.13.2 Top investment pockets
3.13.3 Top winning strategies
3.14 Porters five forces analysis
3.14.1 High competition and large number reduces the power of suppliers
3.14.2 Scattered nature and large count of end users moderates the buyer power
3.14.3 High capital cost lowers the threat of new entrants
3.14.4 Industry rivalry is intense due to presence of few dominant competitors
3.14.5 Lack of efficient substitutes lowers the threat from substitutes
3.15 Value chain analysis
3.16 Patent analysis
3.16.1 Patent analysis by type of patents
3.16.2 Patents Analysis by geography
3.17 Regulatory issues and legislations
3.18 Insurance reimbursement scenario
3.19 Clinical trials
3.19.1 Trial 1: To study the DHEA outcomes on poor responders of IVF
3.19.2 Trial 2: Use of Metformin in IVF treatment of polycystic ovary syndrome
3.19.3 Trial 3- Treatment of first line unexplained infertility by IVF and IUI in controlled ovarian stimulation
3.19.4 Trial 4: Fast track to IVF (FASTT) Vs conventional infertility treatment
3.19.5 Trial 5: To study the evaluation of multiple doses of NT100 in women with repeated IVF failures
3.20 Drivers
3.20.1 Delayed pregnancies in women
3.20.2 Rise in global infertility rates
3.20.3 Advancement in technology
3.20.4 Rise in gamete donations
3.20.5 Rise in disposable income
3.20.6 Increase in success rates
3.21 Restraints
3.21.1 Cost constraints
3.21.2 Ethical and legal issues
3.21.3 Multiple pregnancies
3.21.4 Low awareness level
3.22 Opportunities
3.22.1 Fertility tourism
3.22.2 Growing number of fertility clinics
3.22.3 Rise in same sex marriages
CHAPTER 4 GLOBAL IVF DEVICES & CONSUMABLES MARKET BY INSTRUMENTS
4.1 Global IVF market by instrument, 2014-2020, ($million)
4.1.1 Incubators
4.1.1.1 Global IVF incubators market by geography
4.1.2 Cryosystem
4.1.2.1 Global IVF cryosystem market by geography
4.1.3 Imaging system
4.1.3.1 Global IVF Imaging system market by geography
4.1.4 Cabinet (work station)
4.1.4.1 Global IVF cabinets market by geography
4.1.5 Ovum aspiration pump
4.1.5.1 Global IVF ovum aspiration pump market by geography
4.1.6 Sperm separation system
4.1.6.1 Global IVF Sperm separation system market by geography
4.1.7 Micro manipulator system
4.1.7.1 Global IVF Micromanipulator market by geography
4.1.8 Others
4.1.8.1 Global IVF other instruments market by geography
4.2 Accessories and disposables
4.2.1 Semen analysis chamber
4.2.2 Plastic ware
4.2.3 Oocyte retrieval needles
4.2.4 Miscellaneous disposables
4.2.5 Global IVF accessories and disposables market by geography
CHAPTER 5 GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY REAGENTS & MEDIA
5.1 Global IVF market by reagents & media, 2014-2020, ($million)
5.2 Cryopreservation media
5.2.1 Embryo cryopreservation media
5.2.2 Sperm cryopreservation media
5.2.3 Oocyte cryopreservation media
5.2.4 Global IVF cryopreservation media market by geography
5.3 Semen processing media
5.3.1 Global IVF semen processing media market by geography
5.4 Ovum processing media
5.4.1 Global IVF ovum processing media market by geography
5.5 Embryo culture media
5.5.1 Global IVF embryo culture media market by geography
CHAPTER 6 GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY TECHNIQUE
6.1 Global IVF market, by technique, 2014-2020 ($Million)
6.2 Fresh embryo transfer technique
6.2.1 Drivers
6.2.1.1 trends of Delayed pregnancies
6.2.1.2 Growing rates of infertility
6.2.2 Restraints
6.2.2.1 Cost involved in the treatment
6.2.2.2 reimbursements issues with fresh embryo ivf cycles
6.2.3 Global fresh embryo IVF cycle market, by geography
6.3 Frozen Embryo Transfer technique (FER)
6.3.1 Reasons to use this technique
6.3.2 Advantages of Frozen egg IVF technique
6.3.3 Disadvantages of frozen egg IVF technique
6.3.4 Global frozen egg IVF cycle market, by geography
6.4 Donor Egg IVF technique
6.4.1 Benefits of donor egg IVF technique
6.4.2 Risks associated with donor egg IVF cycle technique
6.4.3 Global donor egg IVF cycle market by geography
CHAPTER 7 GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY END USERS
7.1 Global IVF market by end user, 2014-2020 ($Million)
7.2 Hospitals
7.2.1 Global IVF hospitals market by geography
7.3 Surgical centers
7.4 Clinical research institutes
7.4.1 Global IVF clinical research institutes market by geography
7.5 Clinics
7.5.1 Global IVF Clinics market by geography
CHAPTER 8 GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY GEOGRAPHY
8.1 North America
8.1.1 North America IVF devices and consumables market, by country
8.1.1.1 United States IVF devices and consumables market
8.1.1.2 Canada IVF devices and consumables market
8.1.1.3 Mexico IVF devices and consumables market
8.2 Europe
8.2.1 Europe IVF devices and consumables market, by component
8.2.1.1 Germany IVF devices and consumables market
8.2.1.2 France IVF devices and consumables market
8.2.1.3 United Kingdom IVF devices and consumables market
8.2.1.4 Other Europe IVF devices and consumables market
8.3 Asia-Pacific
8.3.1 Asia-Pacific IVF devices & consumables market, by component
8.3.1.1 India IVF devices & consumables market
8.3.1.2 China IVF devices & consumables market
8.3.1.3 Japan IVF devices & consumables market
8.3.1.4 Australia IVF devices & consumables market
8.3.1.5 other Asia-pacific IVF devices & consumables market
8.4 LAMEA
8.4.1 LAMEA IVF devices & consumables market, by component
8.4.1.1 Latin America IVF devices & consumables market
8.4.1.2 Middle East IVF devices & consumables market
8.4.1.3 Africa IVF devices & consumables market
CHAPTER 9 COMPANY PROFILE
9.1 Vitrolife AB
9.1.1 Company overview
9.1.2 Business performance
9.1.3 Strategic moves and developments
9.1.4 SWOT analysis of Vitrolife AB
9.2 EMD Serono, Inc.
9.2.1 Company overview
9.2.2 Business performance
9.2.3 Strategic moves and developments
9.2.4 SWOT analysis of EMD Serono, Inc.
9.3 Irvine Scientific
9.3.1 Company overview
9.3.2 Business performance
9.3.3 Strategic moves and developments
9.3.4 SWOT analysis of Irvine scientific
9.4 CooperSurgical, Inc. (Origio)
9.4.1 Company overview
9.4.2 Business performance
9.4.3 Strategic moves and developments
9.4.4 SWOT analysis of CooperSurgical, Inc.
9.5 Cook Medical, Inc.
9.5.1 Company overview
9.5.2 Strategic moves and developments
9.5.3 SWOT analysis of Cook medical, Inc.
9.6 Thermo Fisher Scientific Inc.
9.6.1 Company overview:
9.6.2 Business performance
9.6.3 Strategic moves and developments
9.6.4 SWOT analysis of Thermo Fisher Scientific, Inc.
9.7 Genea Biomedx
9.7.1 Company overview
9.7.2 Strategic moves and developments
9.7.3 SWOT Analysis of Genea Biomedx
9.8 Auxogyn, Inc.
9.8.1 Company overview
9.8.2 Strategic moves and developments
9.8.2.1 Primary strategies
9.8.2.2 Other strategies
9.8.3 SWOT Analysis of Auxogyn, Inc.
9.9 Oxford Gene Technology
9.9.1 Company overview
9.9.2 Strategic moves and developments
9.9.3 SWOT analysis of Oxford Gene Technology
9.10 Ovascience Inc.
9.10.1 Company overview
9.10.2 Business performance
9.10.3 Strategic moves and developments
9.10.4 SWOT analysis of OvaScience, Inc.
LIST OF TABLES
TABLE 1 COMPARISON BETWEEN IUI AND IVF PROCEDURES
TABLE 2 COMPARISON BETWEEN GIFT AND IVF TECHNOLOGY
TABLE 3 COMPARISON BETWEEN ZIFT AND IVF TECHNOLOGY
TABLE 4 COST OF DONOR EGG PROCEDURE IN UNITED STATES (2014)
TABLE 5 COST OF SPERM DONATION (2014)
TABLE 6 AVERAGE SURROGACY COSTS, 2014
TABLE 7 COMPARISON BETWEEN TRADITIONAL AND GESTATIONAL SURROGACY
TABLE 8 COMPARISON BETWEEN MINI IVF AND CONVENTIONAL IVF TECHNOLOGY
TABLE 9 APPLICATIONS OF PGD TECHNOLOGY
TABLE 10 PRODUCT LAUNCH AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES AND COMSUMABLES MARKET, 2012-2015
TABLE 11 AGREEMENT AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES AND COMSUMABLES MARKET, 20122015
TABLE 12 COLLABORATION AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES AND COMSUMABLES MARKET, 2012-2015
TABLE 13 INSURANCE COVERAGE FOR COUNTRIES
TABLE 14 INFERTILITY RATES IN NORTH AMERICA
TABLE 15 GLOBAL DISPOSABLE INCOME, 2014-2021
TABLE 16 IVF SUCCESS RATES BY AGE, EUROPE
TABLE 17 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY INSTRUMENT TYPES, 2014-2020 ($MILLION)
TABLE 18 TECHNOLOGICAL VARIABLES FOR COMMERCIAL IVF INCUBATORS
TABLE 19 GLOBAL IVF INCUBATORS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 20 GLOBAL IVF CRYOSYSTEM MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 21 GLOBAL IVF IMAGING SYSTEM MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 22 GLOBAL IVF CABINETS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 23 GLOBAL IVF OVUM APIRATION PUMP MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 24 MOTILITY OF SPERMS RETRIEVED THROUGH SPERM SEPARATION SYSTEM
TABLE 25 GLOBAL IVF SPERM SEPARATION SYSTEM MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 26 GLOBAL IVF MICROMANIPULATOR MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 27 GLOBAL IVF OTHER INSTRUMENTS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 28 GLOBAL IVF ACCESSORIES AND DISPOSABLE MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 29 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY REAGENTS AND MEDIA TYPES, 2014-2020 ($MILLION)
TABLE 30 ADVANTAGES AND DISADVANTAGES OF CRYOPRESERVATION PROCEDURES
TABLE 31 CRYOPRESERVATION MEDIA BY VARIOUS COMPANIES
TABLE 32 GLOBAL IVF CRYOPRESERVATION MEDIA MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 33 COMMERCIALLY AVAILABLE SPERM PROCESSING MEDIA IN THE MARKET
TABLE 34 GLOBAL IVF SEMEN PROCESSING MEDIA MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 35 GLOBAL IVF OVUM PROCESSING MEDIA MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 36 EMBRYO CULTURE MEDIA BY VARIOUS COMPANIES
TABLE 37 GLOBAL IVF EMBRYO CULTURE MEDIA MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 38 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY TECHNIQUE, 2014-2020 ($MILLION)
TABLE 39 GLOBAL FRESH EMBRYO IVF CYCLE MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 40 COMPARISON BETWEEN FRESH AND FROZEN EMBRYO TRANSFER PROCEDURES
TABLE 41 GLOBAL FROZEN EGG IVF CYCLE MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 42 GLOBAL DONOR EGG IVF CYCLE MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 43 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY END USERS, 2014-2020 ($MILLION)
TABLE 44 GLOBAL IVF HOSPITALS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 45 GLOBAL IVF SURGICAL CENTERS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 46 GLOBAL IVF CLINICAL RESEARCH INSTITUTES MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 47 GLOBAL IVF CLINICS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 48 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY GEOGRAPHY, 20142020 ($MILLION)
TABLE 49 REGULATORY SCENARIO, NORTH AMERICA
TABLE 50 NORTH AMERICA IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 20142020 ($MILLION)
TABLE 51 EUROPE IVF CYCLES IN 2014
TABLE 52 REGULATORY SCENARIO IN MANUFACTURING OF IVF DEVICES IN EUROPE
TABLE 53 REGULATORY SCENARIO, EUROPE
TABLE 54 EUROPE IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 20142020 ($MILLION)
TABLE 55 POLICIES BY ASIAN COUNTRIES TO SUPPORT ART TREATMENT
TABLE 56 ASIA-PACIFIC IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 20142020 ($MILLION)
TABLE 57 TYPE OF DATA COMPONENTS AND THEIR REQUIREMENTS
TABLE 58 REGULATORY SCENARIO, LAMEA
TABLE 59 LAMEA IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 20142020 ($MILLION)
TABLE 60 VITROLIFE AB BUSINESS SNAPSHOT
TABLE 61 EMD SERONO, INC BUSINESS SNAPSHOT
TABLE 62 IRVINE SCIENTIFIC BUSINESS SNAPSHOT
TABLE 63 COOPER SURGICAL, INC. BUSINESS SNAPSHOT
TABLE 64 COOK MEDICAL, INC. BUSINESS SNAPSHOT
TABLE 65 THERMO FISHER SCIENTIFIC INC. BUSINESS SNAPSHOT
TABLE 66 GENEA BIOMEDX BUSINESS SNAPSHOT
TABLE 67 AUXOGYN, INC. BUSINESS SNAPSHOT
TABLE 68 OXFORD GENE TECHNOLOGY BUSINESS SNAPSHOT
TABLE 69 OVASCIENCE, INC. BUSINESS SNAPSHOT
TABLE 1 COMPARISON BETWEEN IUI AND IVF PROCEDURES
TABLE 2 COMPARISON BETWEEN GIFT AND IVF TECHNOLOGY
TABLE 3 COMPARISON BETWEEN ZIFT AND IVF TECHNOLOGY
TABLE 4 COST OF DONOR EGG PROCEDURE IN UNITED STATES (2014)
TABLE 5 COST OF SPERM DONATION (2014)
TABLE 6 AVERAGE SURROGACY COSTS, 2014
TABLE 7 COMPARISON BETWEEN TRADITIONAL AND GESTATIONAL SURROGACY
TABLE 8 COMPARISON BETWEEN MINI IVF AND CONVENTIONAL IVF TECHNOLOGY
TABLE 9 APPLICATIONS OF PGD TECHNOLOGY
TABLE 10 PRODUCT LAUNCH AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES AND COMSUMABLES MARKET, 2012-2015
TABLE 11 AGREEMENT AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES AND COMSUMABLES MARKET, 20122015
TABLE 12 COLLABORATION AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES AND COMSUMABLES MARKET, 2012-2015
TABLE 13 INSURANCE COVERAGE FOR COUNTRIES
TABLE 14 INFERTILITY RATES IN NORTH AMERICA
TABLE 15 GLOBAL DISPOSABLE INCOME, 2014-2021
TABLE 16 IVF SUCCESS RATES BY AGE, EUROPE
TABLE 17 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY INSTRUMENT TYPES, 2014-2020 ($MILLION)
TABLE 18 TECHNOLOGICAL VARIABLES FOR COMMERCIAL IVF INCUBATORS
TABLE 19 GLOBAL IVF INCUBATORS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 20 GLOBAL IVF CRYOSYSTEM MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 21 GLOBAL IVF IMAGING SYSTEM MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 22 GLOBAL IVF CABINETS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 23 GLOBAL IVF OVUM APIRATION PUMP MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 24 MOTILITY OF SPERMS RETRIEVED THROUGH SPERM SEPARATION SYSTEM
TABLE 25 GLOBAL IVF SPERM SEPARATION SYSTEM MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 26 GLOBAL IVF MICROMANIPULATOR MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 27 GLOBAL IVF OTHER INSTRUMENTS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 28 GLOBAL IVF ACCESSORIES AND DISPOSABLE MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 29 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY REAGENTS AND MEDIA TYPES, 2014-2020 ($MILLION)
TABLE 30 ADVANTAGES AND DISADVANTAGES OF CRYOPRESERVATION PROCEDURES
TABLE 31 CRYOPRESERVATION MEDIA BY VARIOUS COMPANIES
TABLE 32 GLOBAL IVF CRYOPRESERVATION MEDIA MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 33 COMMERCIALLY AVAILABLE SPERM PROCESSING MEDIA IN THE MARKET
TABLE 34 GLOBAL IVF SEMEN PROCESSING MEDIA MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 35 GLOBAL IVF OVUM PROCESSING MEDIA MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 36 EMBRYO CULTURE MEDIA BY VARIOUS COMPANIES
TABLE 37 GLOBAL IVF EMBRYO CULTURE MEDIA MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 38 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY TECHNIQUE, 2014-2020 ($MILLION)
TABLE 39 GLOBAL FRESH EMBRYO IVF CYCLE MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 40 COMPARISON BETWEEN FRESH AND FROZEN EMBRYO TRANSFER PROCEDURES
TABLE 41 GLOBAL FROZEN EGG IVF CYCLE MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 42 GLOBAL DONOR EGG IVF CYCLE MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 43 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY END USERS, 2014-2020 ($MILLION)
TABLE 44 GLOBAL IVF HOSPITALS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 45 GLOBAL IVF SURGICAL CENTERS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 46 GLOBAL IVF CLINICAL RESEARCH INSTITUTES MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 47 GLOBAL IVF CLINICS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 48 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY GEOGRAPHY, 20142020 ($MILLION)
TABLE 49 REGULATORY SCENARIO, NORTH AMERICA
TABLE 50 NORTH AMERICA IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 20142020 ($MILLION)
TABLE 51 EUROPE IVF CYCLES IN 2014
TABLE 52 REGULATORY SCENARIO IN MANUFACTURING OF IVF DEVICES IN EUROPE
TABLE 53 REGULATORY SCENARIO, EUROPE
TABLE 54 EUROPE IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 20142020 ($MILLION)
TABLE 55 POLICIES BY ASIAN COUNTRIES TO SUPPORT ART TREATMENT
TABLE 56 ASIA-PACIFIC IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 20142020 ($MILLION)
TABLE 57 TYPE OF DATA COMPONENTS AND THEIR REQUIREMENTS
TABLE 58 REGULATORY SCENARIO, LAMEA
TABLE 59 LAMEA IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 20142020 ($MILLION)
TABLE 60 VITROLIFE AB BUSINESS SNAPSHOT
TABLE 61 EMD SERONO, INC BUSINESS SNAPSHOT
TABLE 62 IRVINE SCIENTIFIC BUSINESS SNAPSHOT
TABLE 63 COOPER SURGICAL, INC. BUSINESS SNAPSHOT
TABLE 64 COOK MEDICAL, INC. BUSINESS SNAPSHOT
TABLE 65 THERMO FISHER SCIENTIFIC INC. BUSINESS SNAPSHOT
TABLE 66 GENEA BIOMEDX BUSINESS SNAPSHOT
TABLE 67 AUXOGYN, INC. BUSINESS SNAPSHOT
TABLE 68 OXFORD GENE TECHNOLOGY BUSINESS SNAPSHOT
TABLE 69 OVASCIENCE, INC. BUSINESS SNAPSHOT
LIST OF FIGURES
FIG. 1 IVF DEVICES AND CONSUMABLES MARKET DEFINITION
FIG. 2 ASIA-PACIFIC ADOPTION RATE BY TYPE OF SURROGACY
FIG. 3 TOP IMPACTING FACTORS (2014-2020)
FIG. 4 TOP INVESTMENT POCKETS OF GLOBAL IVF DEVICES AND CONSUMABLES MARKET (2014-2020)
FIG. 5 TOP WINNING STRATEGIES IN GLOBAL IVF DEVICES AND CONSUMABLES MARKET 20122015
FIG. 6 TOP WINNING STRATEGIES IN GLOBAL IVF DEVICES AND CONSUMABLES MARKET, 2012-2015
FIG. 7 PORTERS FIVE FORCES ANALYSIS
FIG. 8 VALUE CHAIN ANALYSIS OF GLOBAL IVF MARKET
FIG. 9 PATENT ANALYSIS BY TYPE OF PATENTS (2011-2015)
FIG. 10 PATENT ANALYSIS BY GEOGRAPHY (2011-2015)
FIG. 11 EFFECT OF AGE ON FERTILITY
FIG. 12 COMPARISON OF THE MEDIA USED IN EMBRYO CULTURE
FIG. 13 SUCCESS RATE OF IVF TECHNIQUES PERFORMED BY AGE, 2013, U.S.
FIG. 14 PREGNANCY RATE, PER FROZEN EMBRYO TRANSFER, 2013 (U.S.)
FIG. 15 VITROLIFE AB, SALES PER REGION, 2014
FIG. 16 VITROLIFE AB, REVENUES ($MILLION), 2012-2014
FIG. 17 SWOT ANALYSIS OF VITROLIFE AB
FIG. 18 EMD SERONO SALES BY REGION, 2012
FIG. 19 SWOT ANALYSIS OF EMD SERONO, INC.
FIG. 20 SWOT ANALYSIS OF IRVINE SCIENTIFIC
FIG. 21 SWOT ANALYSIS OF COOPER SURGICAL, INC.
FIG. 22 SWOT ANALYSIS OF COOK MEDICAL, INC.
FIG. 23 THERMO FISHER SCIENTIFIC, INC. FINANCIAL REVENUES BY BUSINESS UNITS (2013)
FIG. 24 FINANCIAL REVENUES BY GEOGRAPHIC AREAS (2013)
FIG. 25 SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC, INC.
FIG. 26 SWOT ANALYSIS OF GENEA BIOMEDX
FIG. 27 SWOT ANALYSIS OF AUXOGYN, INC.
FIG. 28 SWOT ANALYSIS OF OXFORD GENE TECHNOLOGY
FIG. 29 SWOT ANALYSIS OF OVASCIENCE, INC.
FIG. 1 IVF DEVICES AND CONSUMABLES MARKET DEFINITION
FIG. 2 ASIA-PACIFIC ADOPTION RATE BY TYPE OF SURROGACY
FIG. 3 TOP IMPACTING FACTORS (2014-2020)
FIG. 4 TOP INVESTMENT POCKETS OF GLOBAL IVF DEVICES AND CONSUMABLES MARKET (2014-2020)
FIG. 5 TOP WINNING STRATEGIES IN GLOBAL IVF DEVICES AND CONSUMABLES MARKET 20122015
FIG. 6 TOP WINNING STRATEGIES IN GLOBAL IVF DEVICES AND CONSUMABLES MARKET, 2012-2015
FIG. 7 PORTERS FIVE FORCES ANALYSIS
FIG. 8 VALUE CHAIN ANALYSIS OF GLOBAL IVF MARKET
FIG. 9 PATENT ANALYSIS BY TYPE OF PATENTS (2011-2015)
FIG. 10 PATENT ANALYSIS BY GEOGRAPHY (2011-2015)
FIG. 11 EFFECT OF AGE ON FERTILITY
FIG. 12 COMPARISON OF THE MEDIA USED IN EMBRYO CULTURE
FIG. 13 SUCCESS RATE OF IVF TECHNIQUES PERFORMED BY AGE, 2013, U.S.
FIG. 14 PREGNANCY RATE, PER FROZEN EMBRYO TRANSFER, 2013 (U.S.)
FIG. 15 VITROLIFE AB, SALES PER REGION, 2014
FIG. 16 VITROLIFE AB, REVENUES ($MILLION), 2012-2014
FIG. 17 SWOT ANALYSIS OF VITROLIFE AB
FIG. 18 EMD SERONO SALES BY REGION, 2012
FIG. 19 SWOT ANALYSIS OF EMD SERONO, INC.
FIG. 20 SWOT ANALYSIS OF IRVINE SCIENTIFIC
FIG. 21 SWOT ANALYSIS OF COOPER SURGICAL, INC.
FIG. 22 SWOT ANALYSIS OF COOK MEDICAL, INC.
FIG. 23 THERMO FISHER SCIENTIFIC, INC. FINANCIAL REVENUES BY BUSINESS UNITS (2013)
FIG. 24 FINANCIAL REVENUES BY GEOGRAPHIC AREAS (2013)
FIG. 25 SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC, INC.
FIG. 26 SWOT ANALYSIS OF GENEA BIOMEDX
FIG. 27 SWOT ANALYSIS OF AUXOGYN, INC.
FIG. 28 SWOT ANALYSIS OF OXFORD GENE TECHNOLOGY
FIG. 29 SWOT ANALYSIS OF OVASCIENCE, INC.
